Tomoharu Sugie
- Immunology top 5%
- Immunotherapy and Immune Responses 17
- Immune Cell Function and Interaction 12
- Cancer Research top 5%
- Breast Cancer Treatment Studies 16
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 16
- HER2/EGFR in Cancer Research 8
- CAR-T cell therapy research 8
- Cancer Cells and Metastasis 7
-
- Breast Lesions and Carcinomas 11
- Co-authors
- Masakazu ToiNagahiro MinatoYoshimasa TanakaTakafumi IkedaKaoru Murata‐HiraiShotaro KanaoMasashi IwasakiAkira Shimizu
- Cited by
- ImmunologyCancer ResearchOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (3 papers)Blood (1 paper)
- Partner nations
- JapanUnited StatesEgypt
In The Last Decade
Tomoharu Sugie
82 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 107
- Immunology 674
- Cancer Research 457
- Oncology 656
- Pathology and Forensic Medicine 326
- Radiology, Nuclear Medicine and Imaging 264
Countries citing papers authored by Tomoharu Sugie
This map shows the geographic impact of Tomoharu Sugie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoharu Sugie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoharu Sugie more than expected).
Fields of papers citing papers by Tomoharu Sugie
This network shows the impact of papers produced by Tomoharu Sugie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoharu Sugie. The network helps show where Tomoharu Sugie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoharu Sugie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 7 | |
| 3 | 2020 | 16 | |
| 4 | 2020 | 15 | |
| 5 | 2016 | 80 | |
| 6 | 2015 | 63 | |
| 7 | 2013 | 39 | |
| 8 | 2013 | 123 | |
| 9 | 2012 | 32 | |
| 10 | 2011 | 17 | |
| 11 | 2010 | 132 | |
| 12 | [A case of HER2-positive metastatic breast cancer responding to trastuzumab plus gemcitabine combination therapy]. | 2008 | 1 |
| 13 | 2007 | 0 | |
| 14 | 2007 | 28 | |
| 15 | 1998 | 18 | |
| 16 | 1998 | 2 | |
| 17 | 1997 | 15 | |
| 18 | 1993 | 1 | |
| 19 | 1991 | 5 | |
| 20 | 1963 | 27 |
About Tomoharu Sugie
Tomoharu Sugie is a scholar working on Cancer Research, Oncology and Immunology, having authored 87 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Breast Cancer Treatment Studies (16 papers), Immune Cell Function and Interaction (12 papers), Breast Lesions and Carcinomas (11 papers), HER2/EGFR in Cancer Research (8 papers), CAR-T cell therapy research (8 papers) and Cancer Cells and Metastasis (7 papers). The work is most often cited by research in Immunology (674 citations), Cancer Research (457 citations) and Oncology (656 citations). Tomoharu Sugie has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Masakazu Toi, Nagahiro Minato, Yoshimasa Tanaka, Takafumi Ikeda, Kaoru Murata‐Hirai, Shotaro Kanao, Masashi Iwasaki, Akira Shimizu, Michihiro Iwashiro and Kim J. Hasenkrug. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.